GAMMA Investing
USNA icon

GAMMA Investing’s Usana Health Sciences USNA Stock Holding History

GAMMA Investing’s Portfolio USNA Stock Details USNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$40K Buy
2,763
+2,413
+689% +$41.5K ﹤0.01% 2529
2026
Q2 		$7.47K Buy
350
+91
+35% +$1.71K ﹤0.01% 3326
2026
Q1 		$4.53K Buy
259
+104
+67% +$2.06K ﹤0.01% 3395
2025
Q4 		$3.04K Sell
155
-623
-80% -$12.9K ﹤0.01% 3470
2025
Q3 		$21.4K Buy
778
+58
+8% +$1.78K ﹤0.01% 2476
2025
Q2 		$22K Buy
720
+410
+132% +$11.6K ﹤0.01% 2403
2025
Q1 		$8.36K Buy
310
+293
+1,724% +$9.28K ﹤0.01% 2838
2024
Q4 		$610 Sell
17
-171
-91% -$6.39K ﹤0.01% 3538
2024
Q3 		$7.13K Sell
188
-144
-43% -$5.92K ﹤0.01% 2594
2024
Q2 		$15K Buy
332
+216
+186% +$9.94K ﹤0.01% 2035
2024
Q1 		$5.63K Buy
116
+104
+867% +$5.09K ﹤0.01% 2359
2023
Q4 		$562 Buy
+12
New +$607 ﹤0.01% 2938

Other funds holding USNA

VCM
Versant Capital Management Phoenix, Arizona $1.17B AUM 28.44% 1-Year Est. Return
Farther Finance Advisors
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
FFO
Fortitude Family Office Scottsdale, Arizona $586M AUM 20.58% 1-Year Est. Return
MassMutual Private Wealth & Trust
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
EP
Essential Partners Rancho Santa Fe, California $219M AUM 37.92% 1-Year Est. Return

GAMMA Investing's USNA Position: Q3 2026 in Review

GAMMA Investing increased its Usana Health Sciences (USNA) stake by 689% in Q3 2026, buying an estimated $41.5K and bringing the position to 2,763 shares worth $40K. The position accounts for ﹤0.01% of the portfolio, ranked #2529.

GAMMA Investing first reported a position in USNA in Q4 2023 and has held it in 12 quarters since. 6 funds tracked by Wall St. Rank hold USNA as of Q3 2026.

  • GAMMA Investing held 2,763 shares of Usana Health Sciences worth $40K as of Q3 2026.
  • GAMMA Investing bought 2,413 Usana Health Sciences shares in Q3 2026, an estimated $41.5K.
  • Usana Health Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2529 holding.
  • GAMMA Investing first reported a position in Usana Health Sciences in Q4 2023 and has held it in 12 quarters since.
  • 6 funds tracked by Wall St. Rank held Usana Health Sciences as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.